Europeiska unionen - kroatiska - EMA (European Medicines Agency)

mylan ireland limited - abirateron acetat - prostatske neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hipofiza i hipotalamusni hormoni i analozi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - hipofiza i hipotalamusni hormoni i analozi - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostatske neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

novartis europharm limited - everolimus - carcinoma, renal cell; breast neoplasms; pancreatic neoplasms - antineoplastična sredstva - hormon-receptor pozitivnim čest grudi cancerafinitor indiciran za liječenje hormon-receptor pozitivan, i her2/neu-negativan preliminarnim raka dojke, u kombinaciji s exemestane, u post-menopausal žene bez simptomatske brutalna patologije nakon recidiva ili progresije bolesti nakon non-steroidal i abs битор. Нейроэндокринные tumora gušterače originafinitor indiciran za liječenje operirati ili метастатической, dobro ili umjereno diferencirani нейроэндокринные tumora gušterače podrijetla u odraslih s прогрессирующим bolest. Нейроэндокринные tumora gastrointestinalnog trakta ili pluća originafinitor indiciran za liječenje operirati ili метастатической dobro diferenciranih (klase 1 ili klase 2) нефункционирующие нейроэндокринные tumora gastrointestinalnog ili plućne bolesti podrijetla u odraslih s прогрессирующим bolest. Почечно-stanični carcinomaafinitor indiciran za liječenje bolesnika s prevladava почечно-stanica karcinoma, bolesti koje развивало nakon obrade na vegf-таргетной terapija.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

eli lilly nederland b.v. - glukagon - Šećerna bolest - hormoni pankreasa hormoni glycogenolytic - baqsimi naznačeno za liječenje teške hipoglikemije kod odraslih, djece i adolescenata u dobi od 4 i više godina s dijabetesom.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

tetris pharma b.v - glukagon - Šećerna bolest - hormoni pankreasa hormoni glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

gedeon richter ltd  - ulipristal acetat - uterusa - spolni hormoni i modulatori genitalnog sustava, - ulipristal acetat je indicirana preoperativna liječenja umjerene do jake simptome mioma u odraslih žena reproduktivne dobi. ulipristal acetat je indiciran za prekidima liječenje umjerene do teške simptome uterine fibroids kod odraslih žena reproduktivne dobi.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

gedeon richter plc. - ulipristal acetat - uterusa - spolni hormoni i modulatori genitalnog sustava, - ulipristal acetat je naveden za jedan tretman предоперационного liječenje umjerene do teške simptome uterine fibroids kod odraslih žena reproduktivne dobi. ulipristal acetat je indiciran za prekidima liječenje u среднетяжелых i teške simptome uterine fibroids kod odraslih žena reproduktivne dobi, koji nemaju pravo na operaciju.

Europeiska unionen - kroatiska - EMA (European Medicines Agency)

theramex ireland limited - nomegestrol acetat, estradiol - kontracepcija - spolni hormoni i modulatori genitalnog sustava, - oral contraception,.